ArticleJournal of Indian Association of Pediatric Surgeons
Efficacy and Safety of Polyethylene Glycol versus Placebo in Pediatric Foreign-body Ingestion: A Randomized Pilot Trial.
Article in Journal of Indian Association of Pediatric Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Foreign body ingestion (FBI) is common in children, with 10%-20% requiring endoscopic intervention and 1% requiring surgery. Despite its frequency, evidence supporting the use of laxatives in FBI is scarce, limited to case reports, case series, and expert opinions. This pilot randomized controlled trial (RCT) evaluated the feasibility of a larger RCT assessing polyethylene glycol (PEG) versus placebo in pediatric FBI. Methods: Children aged 1-18 years with the FBI were randomized to receive PEG (1 g/kg/day) or aspartame placebo (8 mg/kg/day) until foreign body passage or a maximum of 7 days. Feasibility outcomes included recruitment, retention, adherence, acceptability, and tolerability. The primary efficacy outcome (hypothesis-generating) was foreign-body transit time. Results: Among 69 children (71 FBIs), retention was 100%, and adherence was 96%. The acceptability and satisfaction scores were high (4.9/5 and 4.7/5, respectively). No adverse events were reported. The mean FB transit time was shorter in the PEG group than in the placebo (55.8 ± 39.3 vs. 86.8 ± 66.9 h; Conclusion: A randomized trial of PEG in pediatric FBI is feasible, well accepted, and safe. Preliminary findings suggest PEG may enhance foreign body transit, particularly in older children, supporting the rationale for a larger, adequately powered RCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.